scholarly article | Q13442814 |
P2093 | author name string | Rong Rong | |
Steve K Landas | |||
George P Christophi | |||
Paul T Massa | |||
Philip G Holtzapple | |||
P2860 | cites work | Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease | Q22251069 |
Genomic views of STAT function in CD4+ T helper cell differentiation | Q24628039 | ||
Review of the activation of TGF-beta in immunity | Q24635194 | ||
Genome-wide association identifies multiple ulcerative colitis susceptibility loci | Q27865246 | ||
Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract | Q28282472 | ||
ADAM8: a new therapeutic target for asthma | Q28590394 | ||
Protein tyrosine phosphatases in the JAK/STAT pathway | Q28646447 | ||
The regulation of IL-10 production by immune cells | Q29615479 | ||
Inflammatory bowel disease | Q29615500 | ||
Inflammatory bowel disease | Q29616286 | ||
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis | Q30434426 | ||
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay | Q30497815 | ||
Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples | Q30974811 | ||
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. | Q33340603 | ||
Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue | Q33513066 | ||
Gene expression in formalin-fixed paraffin-embedded lymph nodes | Q33613369 | ||
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. | Q33904273 | ||
Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. | Q38415968 | ||
Value of mucosal assessment and biomarkers in inflammatory bowel disease | Q39866439 | ||
Arginase-1-expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris. | Q40409458 | ||
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. | Q40453982 | ||
Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors | Q40701561 | ||
Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness | Q41557347 | ||
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease | Q41844866 | ||
Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. | Q42840078 | ||
Role of cytokines in inflammatory bowel disease | Q43065113 | ||
Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis | Q43628018 | ||
Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease | Q45177746 | ||
DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells. | Q45955702 | ||
NADPH oxidases contribute to autophagy regulation. | Q45956086 | ||
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa | Q47787205 | ||
Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease | Q47787267 | ||
Increased expression of CCL20 in human inflammatory bowel disease | Q48008663 | ||
Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. | Q53286695 | ||
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. | Q54387452 | ||
The −A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease | Q60023210 | ||
Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease | Q74593708 | ||
Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1 | Q77124651 | ||
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease | Q77626816 | ||
Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice | Q80994922 | ||
Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia | Q82976155 | ||
Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. | Q33905233 | ||
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease | Q33964919 | ||
Cellular and molecular basis for the regulation of inflammation by TGF-beta | Q34028060 | ||
Novel genetic markers in inflammatory bowel disease | Q34233119 | ||
Mucins in the gastrointestinal tract in health and disease | Q34386379 | ||
Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. | Q34574880 | ||
Effect of α4β7 blockade on intestinal lymphocyte subsets and lymphoid tissue development | Q34690080 | ||
Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation | Q34727085 | ||
Intestinal trefoil factor confers colonic epithelial resistance to apoptosis | Q34978197 | ||
STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction | Q35061825 | ||
Diagnostic Problems and Advances in Inflammatory Bowel Disease | Q35105993 | ||
Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease | Q35621619 | ||
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease | Q36370178 | ||
GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors | Q36391825 | ||
Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? | Q36778853 | ||
SOCS proteins, cytokine signalling and immune regulation | Q36831668 | ||
Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers | Q36851776 | ||
Role of arginine metabolism in immunity and immunopathology | Q37034571 | ||
Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells | Q37062143 | ||
NF-kappaB in inflammatory bowel disease | Q37163422 | ||
High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD | Q37286157 | ||
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype | Q37301528 | ||
GWA studies: rewriting the story of IBD. | Q37393352 | ||
T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease | Q37416284 | ||
Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease | Q37468451 | ||
Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity | Q37483190 | ||
Diagnostic standards in the pathology of inflammatory bowel disease | Q37629484 | ||
Disease-associated functions of IL-33: the new kid in the IL-1 family | Q37676926 | ||
Future biologic targets for IBD: potentials and pitfalls | Q37687874 | ||
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? | Q37762230 | ||
Anti-adhesion molecule therapy for inflammatory bowel disease | Q37823325 | ||
SHP-1 in cell-cycle regulation | Q37835343 | ||
Genetics of ulcerative colitis | Q37841401 | ||
Regulation of the DNA methyltransferase by the Ras-AP-1 signaling pathway | Q38299575 | ||
P433 | issue | 12 | |
P921 | main subject | Crohn's disease | Q1472 |
ulcerative colitis | Q1477 | ||
P304 | page(s) | 2342-2356 | |
P577 | publication date | 2012-03-29 | |
P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
P1476 | title | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease | |
P478 | volume | 18 |
Q38694522 | Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models |
Q47292177 | Anti-inflammatory effects and mechanisms of vagal nerve stimulation combined with electroacupuncture in a rodent model of TNBS-induced colitis |
Q98227507 | Assessment of Systemic Genetic Damage in Pediatric Inflammatory Bowel Disease |
Q44091952 | Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease |
Q93074396 | Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions |
Q37238312 | CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. |
Q33864128 | CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo |
Q35860292 | Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis |
Q38286034 | Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future |
Q53539411 | Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis. |
Q35405853 | Effect of Infliximab in oxidised serum albumin levels during experimental colitis |
Q34467240 | Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients |
Q36923640 | Emerging neuropeptide targets in inflammation: NPY and VIP |
Q35067528 | Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung |
Q38880724 | Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation. |
Q38224879 | Experimental appendicitis and appendectomy modulate the CCL20-CCR6 axis to limit inflammatory colitis pathology. |
Q37192429 | Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis |
Q37347795 | Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases |
Q33723775 | Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis |
Q29417001 | Genome-wide diet-gene interaction analyses for risk of colorectal cancer |
Q33755171 | Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease. |
Q41185159 | High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. |
Q35075300 | High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis |
Q37672624 | Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach. |
Q51051024 | Identification of inflammatory bowel disease-related proteins using a reverse k-nearest neighbor search. |
Q34962856 | Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis |
Q39220077 | Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker |
Q43700132 | Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis |
Q64112334 | Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study |
Q38797790 | Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora |
Q47749878 | Integrated strategy of differentially expressed genes associated with ulcerative colitis |
Q38117175 | Investigational cytokine-targeted therapies for ulcerative colitis. |
Q35151385 | Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the VH1-69 germline gene |
Q50042190 | MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1. |
Q50952715 | Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria. |
Q49952999 | Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma |
Q57110341 | Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease |
Q37589114 | NADPH oxidase in brain injury and neurodegenerative disorders |
Q54200104 | No association between the SOCS-1 -1478CA/del polymorphism and ulcerative colitis in Turkish subjects. |
Q50635849 | Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease. |
Q59133604 | Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease |
Q26747744 | Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach |
Q35775371 | Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study. |
Q47146914 | Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health |
Q33857794 | S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer |
Q36708344 | Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire |
Q30659867 | Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal Cancer |
Q90360008 | Taraxacum officinale extract ameliorates dextran sodium sulphate-induced colitis by regulating fatty acid degradation and microbial dysbiosis |
Q87288268 | The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications |
Q26829387 | The regulation of inflammation by interferons and their STATs |
Q38191582 | Therapy with stem cells in inflammatory bowel disease |
Q44696806 | Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study |
Q33592962 | Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients. |